Evidence map›Paper›PMID 34203129›Full record

ReviewAntibiotics (Basel, Switzerland)2021

Bactericidal and Virucidal Activities of Biogenic Metal-Based Nanoparticles: Advances and Perspectives.

Gonzalo Tortella, Olga Rubilar, Paola Fincheira, Joana C Pieretti, Paola Duran, Isabella M Lourenço, Amedea B Seabra

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Trends in nano-platforms for the treatment of viral infectious diseases.The Korean journal of chemical engineering · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Gonzalo TortellaCentro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente (CIBAMA), Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Av. Francisco Salazar 01145, Temuco 4811230, Chile.
Olga RubilarCentro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente (CIBAMA), Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Av. Francisco Salazar 01145, Temuco 4811230, Chile.
Paola FincheiraCentro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente (CIBAMA), Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Av. Francisco Salazar 01145, Temuco 4811230, Chile.
Joana C PierettiCenter for Natural and Human Sciences, Universidade Federal do ABC, Santo André 09210-580, Brazil.
Paola DuranBiocontrol Research Laboratory, Scientific and Technological Bioresource Nucleus, Universidad de La Frontera, Temuco 4811230, Chile.
Isabella M LourençoCenter for Natural and Human Sciences, Universidade Federal do ABC, Santo André 09210-580, Brazil.ORCID 0000-0003-3826-4485
Amedea B SeabraCenter for Natural and Human Sciences, Universidade Federal do ABC, Santo André 09210-580, Brazil.ORCID 0000-0003-0591-0380
Universidad de La Frontera · CLUniversidade Federal do ABC · BR

Funding

ANID/REDES 180003CONICYT/FAPESP 2018/08194-2Project Covid (73) Process number: 23006.002357/2020-20Universidad de La Frontera DI20-1003
6 · The paper itself

Abstract

Much progress has been achieved in the preparation and application of engineered nanoparticles (NPs) in the field of medicine, mainly for antibacterial and antiviral applications. In the war against bacteria and viruses, besides traditional antibiotics and antiviral drugs, metal-based nanoparticles, such as silver (AgNPs), copper (CuNPs), copper oxides (CuO-NPs), iron oxide (FeO-NPs), zinc oxide (ZnO-NPs), and titanium oxide (TiO

Indexed as

antibacterialantimicrobial nanoparticlesantivirusbiogenic synthesismetal nanoparticlesnanobiotecnology

Identifiers

PMID34203129
PMCPMC8300690
OpenAlexW3173458209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.